Arthur M. Cohen & Associates’s Twist Bioscience TWST Stock Holding History

Arthur M. Cohen & Associates’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,708	Closed	-$364K	–	142
2022 Q1	$364K	Hold	4,708	–	–	0.08%	104
2021 Q4	$364K	Hold	4,708	–	–	0.07%	118
2021 Q3	$504K	Hold	4,708	–	–	0.1%	100
2021 Q2	$627K	Buy	4,708 +881	+23%	+$102K	0.12%	94
2021 Q1	$474K	Buy	3,827 +623	+19%	+$94.6K	0.11%	103
2020 Q4	$453K	Hold	3,204	–	–	0.11%	102
2020 Q3	$243K	Buy	+3,204	New	+$199K	0.06%	124

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Arthur M. Cohen & Associates's TWST Position: Q2 2022 in Review

Arthur M. Cohen & Associates sold out of Twist Bioscience (TWST) in Q2 2022, closing a stake of 4,708 shares — an estimated $364K sold.

Arthur M. Cohen & Associates first reported a position in TWST in Q3 2020 and held it in 7 quarters. The position peaked at $627K in Q2 2021. 204 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

Arthur M. Cohen & Associates reported no remaining Twist Bioscience position as of Q2 2022 after selling out during the quarter.
Arthur M. Cohen & Associates sold 4,708 Twist Bioscience shares in Q2 2022, an estimated $364K.
Arthur M. Cohen & Associates first reported a position in Twist Bioscience in Q3 2020 and held it in 7 quarters.
Arthur M. Cohen & Associates's Twist Bioscience position peaked at $627K in Q2 2021.
204 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on Arthur M. Cohen & Associates's 13F filing for Q2 2022, filed 18 Jul 2022.